P.D. : *.- Yondelis is approved for marketing in Canada for ovarian Cancer with what the Unidenses State always presumed would be pioneers in oncology... will have that travel to Mexico or Canada be able to access the Yondelis be just the FDA to stop wasting time since there are patients who do not have
CAMBIO DE DISCURSO : ADIÓS A LA SEGUNDA LÍNEA SCLC-ES EN EEUU Y EN EU ...CAMBIAMOS DISCURSO A MANTENIMIENTO EN FIRTS-LINE ///.... PERO PARA MANTENIMIENTO DE 1a LÍNEA APARECE UN MUY SERIO COMPETIDOR DEL IMFORTE : TARLATAMAB + DURVALUMAB /// IMFORTE EN EU DE UN TAM DE 600 MILLONES A UN MERCADO REAL MUCHO MENOR QUE PODRÍA SER DE TAN SOLO UNOS 85 MILLONES /// 2 DE OCTUBRE DE 2028 ... ES LA FECHA PARA LA POSIBLE LLEGADA DE GENÉRICOS DE LURBINECTEDIN ...
20 mayo 2010
US is with the ass in the air in oncology. Yondelis only Mexico ( STS ) and Canada for Treatment Ovarian Cancer .
P.D. : *.- Yondelis is approved for marketing in Canada for ovarian Cancer with what the Unidenses State always presumed would be pioneers in oncology... will have that travel to Mexico or Canada be able to access the Yondelis be just the FDA to stop wasting time since there are patients who do not have